Bringing the fundamentals into focus…
Back to Kymera Therapeutics, Inc.
How Kymera Therapeutics, Inc. stacks up
KYMR · against 154 other Healthcare companies of similar size
Profitability
12/ 100
Near the bottom of its peers.
Ranked #147 of 155 · scores higher than 5% of peers
Bars: peers in each 10-point band of the profitability score8 peers with a profitability score of 10–19, including KYMR · Click a bar to see the companies
Why profitability scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 92% of peers. Operating margin: -333.5% vs peer median 7.1%
- a lower return on invested capital: weaker than 79% of peers. Return on invested capital: -20.0% vs peer median 4.7%
- a higher return on assets: stronger than 97% of peers. Return on assets: 19.6% vs peer median 1.7%
Metric by metric
Position: dot = KYMR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KYMR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 151 reported | -20.0% | 10.0% | 13% | 33% | |
| Operating marginHigher is better · 148 reported | -333.5% | 14.0% | 3% | 33% | |
| Return on assetsHigher is better · 149 reported | 19.6% | 4.7% | 97% | 33% | |
| Return on equityHigher is better · 144 reported | -24.2% | 9.1% | 16% | Context only | |
| Gross marginHigher is better · 164 reported | -257.7% | 55.2% | 0% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around KYMR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 5 | 18.5B USD | 97 | 62 | |
| 143 | 6.0B USD | 16 | 32 | |
| 144 | 16.5B USD | 15 | 37 | |
| 144 | 5.4B USD | 15 | 38 | |
| 146 | 5.7B USD | 13 | 30 | |
| 147 | 10.5B USD | 12 | 56 | |
| 148 | 14.5B USD | 10 | 30 | |
| 148 | 6.2B USD | 10 | 44 | |
| 148 | 8.8B USD | 10 | 31 | |
| 151 | 7.7B USD | 9 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score